Elsevier Inc.

SHERPA: Unknown

People

  1. Seshan
    Seshan
  2. Rusch
    Rusch
  3. Kris
    Kris
  4. Park
    Park
  5. Bains
    Bains
  6. Heelan
    Heelan
  7. Ladanyi
    Ladanyi
  8. Lee
    Lee
  9. Mechalakos
    Mechalakos
  10. Pfister
    Pfister

Groups

  1. Biostatistics Service (6)
  2. Center for Pancreatic Cancer Research (6)
  3. Epidemiology and Biostatistics (6)
  4. Surgery (6)
  5. Department of Medicine (4)
  6. Solid Tumor Oncology Division (4)
  7. Survivorship Research (4)
  8. Thoracic Oncology (3)
  9. GSK Faculty (2)
  10. Human Oncology and Pathogenesis Program (2)
Search Within
  1. "2007"
  2. "Surgery"
  3. "Venkatraman Seshan"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (6)
  2. Center for Pancreatic Cancer Research (6)
  3. Epidemiology and Biostatistics (6)
  4. Surgery (6)
  5. Department of Medicine (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Venkatraman Seshan (6)
  2. Valerie Rusch (5)
  3. Mark Kris (3)
  4. Maureen Zakowski (3)
  5. Bernard Park (2)
  6. Marc Ladanyi (2)

More People

Years
  1. 2007 (6)
Publications
  1. Journal of Thoracic Oncology (5)
  2. International Journal of Radiation Oncology, Biology, Physics (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Riely, G. J.; Seshan, V. E.; Azzoli, C. G.; Kris, M. G.; Rusch, V. W.; Park, B. K.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Meeting Abstract

    Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Predictors of outcomes after surgical treatment of synchronous primary lung cancers
    Meeting Abstract

    Finley, D. J.; Yoshizawa, A.; Zhou, Q. C.; Seshan, V. E.; Rusch, V. W.; Travis, W. D.; Park, B. J.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Salvage re-irradiation for recurrent head and neck cancer
    Journal Article

    Lee, N.; Chan, K.; Bekelman, J. E.; Zhung, J.; Mechalakos, J.; Narayana, A.; Wolden, S.; Venkatraman, E. S.; Pfister, D.; Kraus, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center
    Journal Article

    Flores, R. M.; Zakowski, M.; Venkatraman, E.; Krug, L.; Rosenzweig, K.; Dycoco, J.; Lee, C.; Yeoh, C.; Bains, M.; Rusch, V.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save